[Special Stock] Dukem Bio Shows Strong Performance on First Day of KOSDAQ Transfer Listing

Radiopharmaceutical specialist Dukem Bio is showing strong performance on its first day of transfer listing on KOSDAQ.

As of 9:50 AM on the 20th, Dukem Bio is trading at 12,060 KRW, up 50.63% from the public offering price of 8,000 KRW.

Previously listed on the KONEX market, Dukem Bio is a subsidiary of GeoYoung, a pharmaceutical wholesale and retail company, and holds over 90% market share in the domestic Alzheimer's disease diagnostic market.

The funds raised through the listing will be used for investment in diagnostic and therapeutic manufacturing facilities, repayment of borrowings, research and development (R&D), and operating expenses.

Earlier, in the demand forecast targeting institutional investors, the public offering price was set at 8,000 KRW, lower than the lower end of the desired price range (12,300 to 14,100 KRW). The subscription for public shares by general investors recorded a competition rate of 172 to 1.

This content was produced with the assistance of AI translation services.